Vorinostat in Treating Patients With Progressive Metastatic Prostate Cancer

Clinical trial NCT00330161 · COMPLETED

Trial details

NCT number: NCT00330161
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Prostate Cancer Stage IV Prostate Cancer

Start date: 2006-03-01
Primary completion: 2009-09-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.